Context Therapeutics CNTX
NASDAQ CNTX
$0.24 +0.00 (+1.82%)
At close: Oct 22, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Cash & Equivalents (2020 - 2026)

Updated

Context Therapeutics' Cash & Equivalents was $43 million in Q2 2026, down 48.5% from $83.52 million a year earlier and down 21.1% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Context Therapeutics came in at $66 million, down 30.1% from FY2024.

  • Cash & Equivalents shows a five-year compound annual growth rate of 186.6% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $94.43 million in FY2024 (+553.5%), $14.45 million in FY2023 (-59.3%), $35.5 million in FY2022 (-28.6%) and $49.69 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q1 2024.
  • Compared with a year earlier, Cash & Equivalents has declined for five straight quarters, with growth averaging 185.6% over the last eight quarters.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q1 2025 (growth of 785.1%); the worst was Q1 2024 (a decline of 66.1%).
  • Per Business Quant data, CNTX's Cash & Equivalents in the three quarters before Q2 2026 was $54.53 million (Q1 2026), $66 million (Q4 2025) and $76.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.90 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 976.00 Mn
10 Context Therapeutics 21.97 Mn -218.49 Mn - 43.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.00 Mn
Mar 31, 2026 54.53 Mn
Dec 31, 2025 66.00 Mn
Sep 30, 2025 76.94 Mn
Jun 30, 2025 83.52 Mn
Mar 31, 2025 89.40 Mn
Dec 31, 2024 94.43 Mn
Sep 30, 2024 84.80 Mn
Jun 30, 2024 101.54 Mn
Mar 31, 2024 10.10 Mn
Dec 31, 2023 14.45 Mn
Sep 30, 2023 21.70 Mn
Jun 30, 2023 25.14 Mn
Mar 31, 2023 29.80 Mn
Dec 31, 2022 35.50 Mn
Sep 30, 2022 39.43 Mn
Jun 30, 2022 42.92 Mn
Mar 31, 2022 45.73 Mn
Dec 31, 2021 49.69 Mn
Sep 30, 2021 419,152.00
API Access

Context Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CNTX&period=max&api_key=YOUR_API_KEY